Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials

Clinical Respiratory Journal

Volumn 3, Issue 3, 2009, Pages 169-180

  Wickstrøm, Jannie ^a   Dam, Nanna ^b   Malmberg, Irena ^b   Hansen, Brian Bekker ^a   Lange, Peter ^c  

^a MUUSMANN ^*  (Denmark)

^b ASTRAZENECA   (United Kingdom)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Asthma; Budesonide formoterol; Cost effectiveness; Symbicort maintenance and reliever therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; SALBUTAMOL; SYMBICORT SMART; TERBUTALINE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DENMARK; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESOURCE MANAGEMENT; RISK REDUCTION; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DENMARK; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ECONOMICS, PHARMACEUTICAL; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68849119077     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2009.00134.x     Document Type: Article

References (32)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2007. Available from URL: http://www.ginasthma.com.
2. 2- agonist. Dansk Sundhedsinstitut. http://www.dsi.dk/Publikationer/Publikationer/ astma1929/Astma%201929%vXXII-110507.pdf
3. Mossing R, Nielsen GD Cost-of-illness of asthma in Denmark in the year 2000 Ugeskr Laeger. 2003 165 (26 2646 9.
4. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms. Lancet. 1994 334 : 219 24.
5. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids. Am J Respir Crit Care Med. 1996 153 : 1481 8.
6. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of inhaled salmeterol in symptomatic asthma (MIASMA). BMJ. 2000 320 : 1368 73. (Pubitemid 30261116)
7. Pauwels RA, Löfdahl C-G, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1997 337 : 1405 11.
8. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001 164 : 1392 7.
9. Price D, Wiren A, Kuna P. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy. Allergy. 2007 62 (10 1189 98. (Pubitemid 47374022)
10. Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med. 2006 100 (3 434 50.
11. McCormack PL, Lyseng-Williamson KA. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. Drugs. 2007 67 (16 2407 31.
12. Akazawa M, Stempel DA. Single-inhaler combination therapy for asthma. A review of cost effectiveness. Pharmacoeconomics. 2006 24 : 971 88.
13. Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. Pharmacoeconomics. 2006 24 (7 695 708.
14. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005 171 (2 129 36.
15. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006 368 (9537 744 53.
16. Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005 26 (5 819 28.
17. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martinez-Jimenez NE, Buhl R. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007 61 (5 725 36. (Pubitemid 46587876)
18. Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med. 2007 101 (12 2437 46.
19. Rabe KF, Pizzichini E, Stællberg B, Romero S, Balanzat AM, Atienza T, Lier PA, Jorup C. Budesonide/formoterol in a single inhaler for maintenance and relief in mild to moderate asthma: a randomized double-blind trial. Chest. 2006 129 : 246 56.
20. Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet L-P, Naya P, Hultquist C. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004 20 (9 1403 18.
21. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekstrøm T, Selroos O. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Curr Med Res Opin. 2006 22 (5 809 21.
22. Amtsrådsforeningen. Amternes Ambulancebetjening 1996-2000: en Analyse af Ambulancekørslen ved Falcks Redningskorps 1996-2000 samt Standardaftalen Mellem Amtsråds-Foreningen og Falcks Redningskorps om Ambulanceberedskab og Ambulancekørsel. Udarbejdet af en Arbejdsgruppe Nedsat af Amtsrådsforeningen. København : Amtsrådsforeningen, 2002.
23. National Board of Health. DAGS tariffs, DK. Available from URL: http://www.sst.dk/Planlaegning-og-behandling/DRG/Takster.aspx?lang=da (Accessed 7 November 2007).
24. Danish Association of Medical Specialists. Tariffs. Available from URL: http://www.laeger.dk/portal/page/portal/LAEGERDK/LAEGER-DK/LOEN-OVERENSKOMSTER/ FAS/PRAKSIS/TAKSTKORT/INTERN-MED (Accessed 3 December 2007).
25. Organisation of General Practitioners in Denmark. Tariffs. Available from URL: http://www.laeger.dk/portal/page/portal/LAEGERDK/LAEGER-DK/LOEN- OVERENSKOMSTER/PLO/Honorartabel/%C2%A7%2068%20Ydelser%20i%20dagtiden1 (Accessed 3 December 2007).
26. Association of Danish Physiotherapists. Tariffs. Available from URL: http://www.fysio.dk/graphics/PDF/Privatogpraksis/Takster/okt%202007/ 51%20takster.pdf (Accessed 3 December 2007).
27. Danish Medicines Agency. Medicin Priser. Available from URL: http://www.medicinpriser.dk (Accessed 7 November 2007).
28. StatisticsDenmark. Danmarks Statistik. Available from URL: http://www.statistikbanken.dk (Accessed 14 September 2007).
29. Odense University Hospital. Takster for indlæggelse og ambulant behandling Odense Universitetshospital i. 2007. Available from URL: http://www.ouh.dk/wm192811 (Accessed 3 December 2007).
30. Sears MR, Boulet LP, Laviolette M, Fitzgerald JM, Bai TR, Kaplan A, Smiljanic-Georgijev N, Lee JSM. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J. 2008 31 : 982 9.
31. Drummond M, Barbieri M, Cook J, et al. Transferability of economic evaluations across jurisdictions. ISPOR good research practices task force report. Value Health. 2009 doi: 10.1111/j.1524-4733.2008.00489.x.
32. O'Sullivan A, Thompson D, Drummond M. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Health. 2005 5 : 67 79.